Clinical Trial Update: Docetaxel in Squamous Cell Carcinoma of the Head and Neck (TAX + Cisplatin in SCCHN) [Phase 1, Phase 2]

View source ↗

Summary

A completed Phase 1/2 clinical trial assessing the combination of docetaxel and cisplatin in head and neck squamous cell carcinoma. The study is sponsored by Sa…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Squamous Cell Carcinoma

Drugs mentioned

• Platinol (cisplatin)
• Taxotere (docetaxel)

Snippet

Sponsor: Sanofi | Conditions: Head and Neck Neoplasms | Phase 1, Phase 2 | Status: COMPLETED